Lido Advisors Reduces $4M in The Cigna Group ($CI)
Lido Advisors reduced its holdings in Cigna by 13,519 shares, a 31% decrease.
Key Points
- Lido Advisors cut its stake in The Cigna Group by 31%, reducing its holdings by 13,519 shares to a total of 29,306 shares valued at $8.72 million.
- Cigna's stock trades near $297.38 with a market cap of $78.83 billion, a P/E ratio of 11.92, and a 52-week range of $239.51 to $338.89.
- Insider activity includes significant transactions by CEO David Cordani, and analysts from firms like Mizuho and Barclays have recently updated their ratings.
Lido Advisors has cut its position in The Cigna Group (NYSE: CI) by 31%, according to its latest 13F filing with the SEC. The filing, reflecting holdings as of the last reporting period, shows that Lido Advisors reduced its holdings by 13,519 shares, bringing its total to 29,306 shares. The current value of this stake is approximately $8.72 million.
What Changed in Lido Advisors' Cigna Position
Lido Advisors significantly reduced its stake in The Cigna Group, cutting 13,519 shares from its previous position of 42,825 shares. This marks a 31% reduction, leaving the fund with 29,306 shares valued at about $8.72 million. The move reflects a strategic decision by the firm to adjust its investment in the healthcare company.
Other Institutional Activity in The Cigna Group
In recent institutional activity, BlackRock, Inc. reduced its holdings in Cigna by 585,855 shares, ending with 22,598,152 shares valued at approximately $6.03 billion. Vanguard Capital Management LLC maintained its position with 17,122,069 shares, valued at $4.57 billion. State Street Corp trimmed its holdings by 56,109 shares to a total of 12,283,141 shares worth $3.28 billion. Massachusetts Financial Services Co /MA/ also reduced its position by 209,901 shares, now holding 11,595,182 shares valued at $3.11 billion. Meanwhile, Dodge & Cox increased its stake by 417,173 shares, bringing its total to 11,555,787 shares valued at $3.08 billion.
The Cigna Group Stock Snapshot
Shares of The Cigna Group (NYSE: CI) traded near $297.38. The company has a market cap of $78.83 billion and a P/E ratio of 11.92. Its forward P/E is approximately 8.90, indicating expectations of future growth. The stock has seen a 52-week low of $239.51 and a high of $338.89. Its 50-day moving average is $282.08, while the 200-day moving average stands at $281.68. The company's beta is 0.302, suggesting lower volatility compared to the market.
Recent Earnings
The Cigna Group reported revenue of $277.89 billion, reflecting a growth rate of 4.6%. The company achieved an earnings per share (EPS) of $25.00, with a net margin of 2.26% and a return on equity (ROE) of 16.27%. The next earnings report is expected on July 30, 2026.
Dividend
The Cigna Group offers an annual dividend rate of $6.24, yielding 2.12%. The dividend payout ratio is 24.36%, indicating a sustainable distribution relative to its earnings.
Insider Buying and Selling at The Cigna Group
Recent insider transactions at The Cigna Group include significant activity by Chairman & CEO David Cordani. On May 13, 2026, Cordani sold 234,290 shares at an average price of $165.54 and executed a planned sale of 201,878 shares at $292.82 on May 12, 2026. EVP and Global CIO Koka Durga Prasad sold 729 shares at $275.53 on June 1, 2026. Meanwhile, George Kurian purchased 108 shares at $277.40 on May 29, 2026.
Analysts Set New Price Targets
On June 8, 2026, Mizuho maintained its 'buy' rating for Cigna with a price target of $340. Barclays downgraded the stock to 'hold' with a $304 target on May 26, 2026. UBS reiterated its 'buy' rating, setting a high target of $400 on May 22, 2026. Morgan Stanley maintained a 'buy' rating with a target of $361 on May 20, 2026. Deutsche Bank also downgraded the stock to 'hold' with a price target of $302 on May 20, 2026.
About The Cigna Group
The Cigna Group, headquartered in Bloomfield, Connecticut, is a major player in the healthcare industry, offering insurance and related services. It operates primarily through its Evernorth Health Services and Cigna Healthcare segments. The company provides a range of services including pharmacy benefit management, medical plans, and health engagement. Led by CEO David Michael Cordani, Cigna employs over 65,000 people and continues to expand its reach through various distribution channels.
Bottom Line
Lido Advisors' decision to trim its stake in The Cigna Group reflects a strategic portfolio adjustment. Investors often track such filings for insights into institutional sentiment, though it's important to remember that 13F filings are historical and may not indicate current positions. Cigna's ongoing performance and analyst ratings suggest a company with stable prospects in the healthcare sector.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.